Shares of Candel Therapeutics Inc. (CADL) surged over 9% on Friday morning, reaching their highest level in nearly a month ...

Century Therapeutics, Candel Therapeutics and MacroGenics have all used their third-quarter earnings releases to disclose how they’re fine-tuning their clinical pipelines to conserve cash. Century has ...

Objective overview of Candel Therapeutics within the biotechnology sector, highlighting developmental activity and scientific ...

Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be available following the event on the Candel website at Candel Media. * Dr.

A clinical-stage biopharmaceutical company looks forward to the year ahead with several promising developments in motion. Focused on the development of multimodal biological immunotherapies to help ...

NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. ("Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...

The latest price target for Candel Therapeutics (NASDAQ:CADL) was reported by HC Wainwright & Co. on April 11, 2025. The analyst firm set a price target for $19.00 expecting CADL to rise to within 12 ...

Candel Therapeutics, Inc. has announced an underwritten public offering to raise $80 million through the sale of its common stock and pre-funded warrants. The company plans to use the proceeds to ...

Candel shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for the treatment of cancer. More than 20.7 million shares have been traded in the session ...

Like many a biotech company in 2021, Candel Therapeutics filed to raise up to $100 million in its IPO. But unlike several of its peers, which outraised that initial figure by two- or even threefold, ...

NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal ...